Agencourt, Ambion Pen Reagent Distribution Deal | GenomeWeb

NEW YORK, Sept. 16 (GenomeWeb News) - Agencourt Bioscience said today that it has signed a distribution agreement with Ambion for its SPRI (Solid-Phase Reversible Immobilization) nucleic acid purification reagent.

Under the terms of the agreement, Ambion will distribute the reagent, called AMPure, as part of its MessageAmp RNA amplification kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.